Over 60 outstanding case studies and presentations
2 day conference covering key insights into Cancer Clinical Trials and Personalized Medicine, Companion Diagnostics Development as well as successful development, design and analysis of clinical trials
Interactive exhibition room for networking activities and one-to-one meetings
Oxford Global is proud to present the Oncology Clinical Development Congress to be held on the 10th -11th October 2012, Manchester. It is to be co-located with our 2nd Annual Oncology Biomarker Congress.
Over the 2 days, the event provides a first class educational and networking opportunity for over 120 attendees to gain knowledge and insights into the Oncology Clinical Development market. The event will bring together key scientists and investigators in oncology clinical trials, clinical R&D, adaptive trials, oncology diagnostics development, and translational research from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.
The programme feature topics on improving safety & risk assessment in Oncology clinical trials and clinical development by implementing biomarkers, manage patient selection & recruitment and identify potential cost savings through successful integration of companion diagnostics and enabling technologies in clinical development. Do not miss out on the opportunity to learn insights on effective development, design and analysis of clinical trials.
This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, analysis of current technologies and their applications, network with their peers and address key industry concerns through a series of cutting edge conference presentations and interactive exhibition room in a professional yet relaxed environment.
Further details and to register
